Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Current Oncology Reports|May 19, 2019
Current Status of Immunotherapies for Treating Pancreatic CancerAnnie A Wu, Elizabeth Jaffee, Valerie LeeThe Lancet. Oncology|March 6, 2020
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright futureEric S Christenson, Elizabeth Jaffee, Nilofer S AzadCancer Letters|January 3, 2016
Current progress in immunotherapy for pancreatic cancerKelly Foley, Victoria Kim, Elizabeth Jaffee, et al.Advances in Immunology|May 30, 2006
Mechanisms of immune evasion by tumorsCharles G Drake, Elizabeth Jaffee, Drew M PardollCell Adhesion & Migration|February 3, 2017
Hedgehog signaling stimulates Tenascin C to promote invasion of pancreatic ductal adenocarcinoma cells through Annexin A2Kelly Foley, Stephen Muth, Elizabeth Jaffee, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Women in oncology: progress, challenges, and keys to successKatherine Reeder-Hayes, Enriqueta Felip, Debra Patt, et al.JCI Insight|March 10, 2021
A global live cell barcoding approach for multiplexed mass cytometry profiling of mouse tumorsSoren Charmsaz, Nicole Gross, Elizabeth Jaffee, et al.Oncotarget|January 27, 2018
Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitorsAdam Diehl, Mark Yarchoan, Alex Hopkins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Immune Therapy in GI Malignancies: A ReviewJudy Wang, Kim A Reiss, Rina Khatri, et al.The Laryngoscope|August 5, 2003
Spatial distribution of tumor vaccine improves efficacyMarion Couch, John K Saunders, Bert W O'Malley, et al.Pageof 5